Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Pradaxa price, strengths & recalls

Brand of dabigatran etexilate (generic)

Pharmacies pay $94.79 for 30 capsules of Pradaxa 150 mg capsule this week, and from $94.79 to $95.01 across its 3 priced strengths and forms. The generic, dabigatran etexilate, costs pharmacies from $21.46. It has 10 recalls on record, none ongoing. Its official label last changed on June 30, 2025.

Brand
Pharmacies pay$94.79for 30 capsules of 150 mg capsuleNo change in 4 weeks
Fair cash price
$119.51
Strengths
3
Makers
1
Updated
Nov 11

Pradaxa price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
75 mg capsule Brand$3.17$95.01 / 30 capsulesNo changeNo change
110 mg capsule Brand$3.17$94.99 / 30 capsulesNo change+0.2%
150 mg capsule Brand$3.16$94.79 / 30 capsulesNo change-0.3%

The lowest cost per capsule is 150 mg capsule at $3.16. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Pradaxa vs generic dabigatran etexilate

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
75 mg capsule$95.01$21.464.4x
110 mg capsule$94.99$26.883.5x
150 mg capsule$94.79$24.013.9x
GenericDabigatran etexilate prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
9 ongoing recalls10 recalls on record, latest Dec 5, 2012

Recalls

Showing the 6 most relevant of 10 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for pradaxa? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJune 30, 2025
Version48 of 37
EffectiveJun 25, 2025
Read the label

These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 2010

This drug has a boxed warning

WARNING: (A) PREMATURE DISCONTINUATION OF PRADAXA INCREASES THE RISK OF THROMBOTIC EVENTS, and (B) SPINAL/EPIDURAL HEMATOMA

WARNING: (A) PREMATURE DISCONTINUATION OF PRADAXA INCREASES THE RISK OF THROMBOTIC EVENTS, and (B) SPINAL/EPIDURAL HEMATOMA

See full prescribing information for complete boxed warning

(A) PREMATURE DISCONTINUATION OF PRADAXA INCREASES THE RISK OF THROMBOTIC EVENTS: Premature discontinuation of any oral anticoagulant, including PRADAXA, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if PRADAXA is discontinued for a reason other than pathological bleeding or completion of a course of therapy (2.6, 2.7, 2.8, 5.1).

(B) SPINAL/EPIDURAL HEMATOMA: Epidural or spinal hematomas may occur in patients treated with PRADAXA who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis (5.3). Monitor patients frequently for signs and symptoms of neurological impairment and if observed, treat urgently. Consider the benefits and risks before neuraxial intervention in patients who are or who need to be anticoagulated (5.3).

(A) PREMATURE DISCONTINUATION OF PRADAXA INCREASES THE RISK OF THROMBOTIC EVENTS

Premature discontinuation of any oral anticoagulant, including PRADAXA, increases the risk of thrombotic events. If anticoagulation with PRADAXA is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant [see Dosage and Administration (2.6, 2.7, 2.8) and Warnings and Precautions (5.1)].

(B) SPINAL/EPIDURAL HEMATOMA

Epidural or spinal hematomas may occur in patients treated with PRADAXA who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:

use of indwelling epidural catheters

concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants

a history of traumatic or repeated epidural or spinal punctures

a history of spinal deformity or spinal surgery

optimal timing between the administration of PRADAXA and neuraxial procedures is not known

[see Warnings and Precautions (5.3)].

Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary [see Warnings and Precautions (5.3)].

Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated [see Warnings and Precautions (5.3)].

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA022512 · Boehringer Ingelheim
First approved
October 19, 2010 (16 years ago)
Latest approved change
June 17, 2025
Approved label
PDF, Oct 3, 2025
Generic makers
8 approved generic applications on the market
Last patent listed
July 20, 2031

Pradaxa questions

How much does pradaxa cost without insurance?

Pharmacies pay about $94.79 for 30 capsules of pradaxa 150 mg capsule ($3.16 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $119.51. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Pradaxa?

Yes: dabigatran etexilate. Pharmacies pay from $21.46 for it. Compare dabigatran etexilate prices.

Is pradaxa in shortage?

No shortage is reported for pradaxa right now. We check the national shortage list every day.

Has pradaxa been recalled?

10 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the pradaxa label last change?

The official label was last updated on June 30, 2025 (version 48). See what changed.

Talk about pradaxa

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.